Alterations of plasma immunoreactive glucagon-like peptide-1 behavior in non-insulin-dependent diabetics
Authors:
- Kenji ShimaKSKenji Shima
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 9 (2) , 179-185
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Isolation and characterisation of GLP‐1 7–36 amide from rat intestine Elevated levels in diabetic ratsFEBS Letters, 1988
- Effect of glucagon-like peptide-1 on insulin secretionRegulatory Peptides, 1988
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987
- A large molecular form of glucagon-like peptide-1(GLP-1) immunoreactivity is co-released with glucagon from pancreas by arginine in normal subjectsClinica Chimica Acta, 1987
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.Journal of Clinical Investigation, 1987
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987
- Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry.Journal of Histochemistry & Cytochemistry, 1985
- Salivary gland glucagon is a fictitious substance due to tracer-degrading activity resistant to protease inhibitorsBiochemical and Biophysical Research Communications, 1983
- Hamster preproglucagon contains the sequence of glucagon and two related peptidesNature, 1983
- The major proglucagon fragment: An abundant islet protein and secretory productFEBS Letters, 1981